Filings Received and Processed at the SEC

Obia Kayla Dean

2123918 ⦿ 0001437749-26-013229

Form 3 Reporting

Laird Superfood, Inc.

1650696 ⦿ 0001437749-26-013229

Form 3 Issuer

NEXUS SPECIAL SITUATIONS III, L.P.

1815325 ⦿ 0001437749-26-013227

Form 4 Reporting

Laird Superfood, Inc.

1650696 ⦿ 0001437749-26-013227

Form 4 Issuer

Gateway Superfood NSSIII Investment, LLC

2127546 ⦿ 0001437749-26-013226

Form 4 Reporting

Nexus Special Situations GP IV, LP

2127212 ⦿ 0001437749-26-013226

Form 4 Reporting

Gateway Superfood NSSIV Investment, LLC

2124520 ⦿ 0001437749-26-013226

Form 4 Reporting

Nexus Partners IV, LLC

2124368 ⦿ 0001437749-26-013226

Form 4 Reporting

Nexus Partners III, LLC

2093669 ⦿ 0001437749-26-013226

Form 4 Reporting

Giangiacomo Damian

2093303 ⦿ 0001437749-26-013226

Form 4 Reporting

Nexus Special Situations GP III, LP

2092583 ⦿ 0001437749-26-013226

Form 4 Reporting

Nexus Capital Management LP

1963997 ⦿ 0001437749-26-013226

Form 4 Reporting

Laird Superfood, Inc.

1650696 ⦿ 0001437749-26-013226

Form 4 Issuer

Flesh Daniel E.

1600232 ⦿ 0001437749-26-013226

Form 4 Reporting

Cohen Michael S

1372171 ⦿ 0001437749-26-013226

Form 4 Reporting

NEXUS SPECIAL SITUATIONS III, L.P.

1815325 ⦿ 0001437749-26-013225

Form 3 Reporting

Laird Superfood, Inc.

1650696 ⦿ 0001437749-26-013225

Form 3 Issuer

Gateway Superfood NSSIII Investment, LLC

2127546 ⦿ 0001437749-26-013224

Form 3 Reporting

Nexus Special Situations GP IV, LP

2127212 ⦿ 0001437749-26-013224

Form 3 Reporting

Gateway Superfood NSSIV Investment, LLC

2124520 ⦿ 0001437749-26-013224

Form 3 Reporting

Nexus Partners IV, LLC

2124368 ⦿ 0001437749-26-013224

Form 3 Reporting

Nexus Partners III, LLC

2093669 ⦿ 0001437749-26-013224

Form 3 Reporting

Giangiacomo Damian

2093303 ⦿ 0001437749-26-013224

Form 3 Reporting

Nexus Special Situations GP III, LP

2092583 ⦿ 0001437749-26-013224

Form 3 Reporting

Nexus Capital Management LP

1963997 ⦿ 0001437749-26-013224

Form 3 Reporting

Laird Superfood, Inc.

1650696 ⦿ 0001437749-26-013224

Form 3 Issuer

Flesh Daniel E.

1600232 ⦿ 0001437749-26-013224

Form 3 Reporting

Cohen Michael S

1372171 ⦿ 0001437749-26-013224

Form 3 Reporting

Gowrishankar Govindan

2069224 ⦿ 0001520138-26-000129

Form 144 Reporting

1606 CORP.

1877461 ⦿ 0001520138-26-000129

Form 144 Subject

Xu John

1980532 ⦿ 0001213900-26-047220

Form 4 Reporting

Maison Solutions Inc.

1892292 ⦿ 0001213900-26-047220

Form 4 Issuer

Golman Jeffrey A

1561001 ⦿ 0001561001-26-000003

Form 4 Reporting

MONROE CAPITAL Corp

1512931 ⦿ 0001561001-26-000003

Form 4 Issuer

X-Energy, Inc.

2088896 ⦿ 0001104659-26-047980

Form S-1MEF Filer

NEONC TECHNOLOGIES HOLDINGS, INC.

1979414 ⦿ 0001213900-26-047218

Form 4 Issuer

Heshmatpour Amir F

1443035 ⦿ 0001213900-26-047218

Form 4 Reporting

Halbower Matthew

2121021 ⦿ 0000902664-26-002119

Form 4 Reporting

Pentwater Capital Management LP

1425851 ⦿ 0000902664-26-002119

Form 4 Reporting

AVIS BUDGET GROUP, INC.

723612 ⦿ 0000902664-26-002119

Form 4 Issuer

McManus Matt

2067206 ⦿ 0001193125-26-174473

Form 4 Reporting

Fold Holdings, Inc.

1889123 ⦿ 0001193125-26-174473

Form 4 Issuer

BBB FOODS INC

1978954 ⦿ 0001140361-26-016502

Form SCHEDULE 13G/A Subject

GIC Private Ltd

936828 ⦿ 0001140361-26-016502

Form SCHEDULE 13G/A Filed by

England Kristin

2078090 ⦿ 0001079973-26-000527

Form 4 Reporting

Oncology Institute, Inc.

1799191 ⦿ 0001079973-26-000527

Form 4 Issuer

Kirwin Patrick D.

1927062 ⦿ 0001104659-26-047977

Form 4 Reporting

ProMIS Neurosciences Inc.

1374339 ⦿ 0001104659-26-047977

Form 4 Issuer

Langsam Jeffrey

2069752 ⦿ 0001079973-26-000525

Form 4 Reporting

Oncology Institute, Inc.

1799191 ⦿ 0001079973-26-000525

Form 4 Issuer

Thompson Teresa Brigid

2089979 ⦿ 0002089979-26-000001

Form 4 Reporting

Synergy CHC Corp.

1562733 ⦿ 0002089979-26-000001

Form 4 Issuer

Paramora Holding LLC

2103411 ⦿ 0001193125-26-174461

Form SCHEDULE 13G/A Filed by

Damora Therapeutics, Inc.

1800315 ⦿ 0001193125-26-174461

Form SCHEDULE 13G/A Subject

Paragon Therapeutics, Inc.

1861055 ⦿ 0001193125-26-174454

Form SCHEDULE 13G/A Filed by

Damora Therapeutics, Inc.

1800315 ⦿ 0001193125-26-174454

Form SCHEDULE 13G/A Subject

Xu Derek

2004130 ⦿ 0001161697-26-000101

Form 4 Reporting

Airship AI Holdings, Inc.

1842566 ⦿ 0001161697-26-000101

Form 4 Issuer

Viant Technology Inc.

1828791 ⦿ 0001284309-26-000012

Form 4 Issuer

MADDEN LARRY

1284309 ⦿ 0001284309-26-000012

Form 4 Reporting

Jacobson Mark L.

1805812 ⦿ 0001193125-26-174419

Form 4 Reporting

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174419

Form 4 Issuer

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174417

Form 4 Issuer

TABUTEAU HERRIOT

1219927 ⦿ 0001193125-26-174417

Form 4 Reporting

Maizel Ari

2042289 ⦿ 0001193125-26-174415

Form 4 Reporting

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174415

Form 4 Issuer

Maizel Ari

2042289 ⦿ 0001193125-26-174413

Form 4 Reporting

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174413

Form 4 Issuer

Pizzie Nick

1742143 ⦿ 0001193125-26-174412

Form 4 Reporting

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174412

Form 4 Issuer

Intrator Michael N

2058037 ⦿ 0001769628-26-000202

Form 4 Reporting

CoreWeave, Inc.

1769628 ⦿ 0001769628-26-000202

Form 4 Issuer

Murdock Hunter R.

1934008 ⦿ 0001193125-26-174411

Form 4 Reporting

Axsome Therapeutics, Inc.

1579428 ⦿ 0001193125-26-174411

Form 4 Issuer

RedCo II Master Fund, L.P.

1921783 ⦿ 0001104659-26-047974

Form 4/A Reporting

Green Jeremy

1650527 ⦿ 0001104659-26-047974

Form 4/A Reporting

FATE THERAPEUTICS INC

1434316 ⦿ 0001104659-26-047974

Form 4/A Issuer

Redmile Group, LLC

1425738 ⦿ 0001104659-26-047974

Form 4/A Reporting

Core Scientific, Inc./tx

1839341 ⦿ 0001011438-26-000252

Form SCHEDULE 13D/A Subject

Two Seas Capital LP

1823138 ⦿ 0001011438-26-000252

Form SCHEDULE 13D/A Filed by

MeiraGTx Holdings plc

1735438 ⦿ 0001193125-26-174407

Form 4 Issuer

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

1249675 ⦿ 0001193125-26-174407

Form 4 Reporting

PERCEPTIVE ADVISORS LLC

1224962 ⦿ 0001193125-26-174407

Form 4 Reporting

EDELMAN JOSEPH

1164426 ⦿ 0001193125-26-174407

Form 4 Reporting

Wellgistics Health, Inc.

2030763 ⦿ 0001493152-26-018820

Form 4 Issuer

Patel Prashant

1617460 ⦿ 0001493152-26-018820

Form 4 Reporting

Pershing Square SPARC Holdings, Ltd./DE

1895582 ⦿ 0001140361-26-016494

Form 4 Issuer

Pershing Square Capital Management, L.P.

1336528 ⦿ 0001140361-26-016494

Form 4 Reporting

PSCM GP, LLC

1336477 ⦿ 0001140361-26-016494

Form 4 Reporting

ACKMAN WILLIAM A

1056513 ⦿ 0001140361-26-016494

Form 4 Reporting

Wellgistics Health, Inc.

2030763 ⦿ 0001493152-26-018817

Form 4 Issuer

AJJARAPU SURENDRA K

1368298 ⦿ 0001493152-26-018817

Form 4 Reporting

Prelude Therapeutics Inc

1678660 ⦿ 0000947871-26-000463

Form SCHEDULE 13D/A Subject

ORBIMED ADVISORS LLC

1055951 ⦿ 0000947871-26-000463

Form SCHEDULE 13D/A Filed by

Baker Brothers Life Sciences LP

1363364 ⦿ 0001104659-26-047969

Form 144 Reporting

Protara Therapeutics, Inc.

1359931 ⦿ 0001104659-26-047969

Form 144 Subject

667, L.P.

1551139 ⦿ 0001104659-26-047967

Form 144 Reporting

Protara Therapeutics, Inc.

1359931 ⦿ 0001104659-26-047967

Form 144 Subject

BFI Co., LLC

1601607 ⦿ 0001104659-26-047964

Form SCHEDULE 13D/A Filed by

PHIBRO ANIMAL HEALTH CORP

1069899 ⦿ 0001104659-26-047964

Form SCHEDULE 13D/A Subject